News and Trends 6 Dec 2022
Tetra announce significant results from the study of Onternabez combined with Favipiravir
Tetra Bio-Pharma Inc. a leader in cannabinoid-derived drug discovery and development announced today significant results from the study of Onternabez combined with Favipiravir. The combination acts against ARDS (acute respiratory…